Journal of Clinical Oncology Alexandria, VA - 22314

Journal of Clinical Oncology is categorized under Periodical Publishers in Alexandria, VA .

Journal of Clinical Oncology was established in 0, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.

If you are seeking more information, feel free to contact Pat Nordine, Director at the company’s single location by writing to 2318 Mill Road # 800, Alexandria, Virginia VA 22314 or by phoning (703) 519-1430. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Journal of Clinical Oncology
Contact Person: Pat Nordine, Director
Address: 2318 Mill Road # 800, Alexandria, Virginia 22314
Phone Number: (703) 519-1430
Website Address: asco.org
Annual Revenue (USD): $50.000.000 to $99.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Periodical Publishers
SIC Code: 2721
NAICS Code: 5111200
Share This Business:

Journal of Clinical Oncology was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.

Feel free to contact Pat Nordine, Director for inquiries that concern Journal of Clinical Oncology by calling the company number (703) 519-1430, as your correspondence is most welcome. Additionally, the physical location of the single location of Journal of Clinical Oncology can be found at the coordinates 38.803712,-77.072289 as well as the street address 2318 Mill Road # 800 in Alexandria, Virginia 22314.

For its online presence, you may visit Journal of Clinical Oncology’s website at asco.org and engage with its social media outlets through on Twitter and on Facebook.